Clinical trials

Below are current clinical trials.

12 studies in CAR-T Cell Therapy Program
(open studies only).

Filter this list of studies by location, status and more.

Oct. 15, 2019
  1. Locke FL, et al. Clinical and biologic covariates of outcomes in zuma-1: A pivotal trial of axicabtagene ciloleucel (AXI-CEL; KTE-C19) in patients with refractory aggressive non-Hodgkin lymphoma (NHL). Presentation. 2017 annual meeting of European Hematology Association, June 24, 2017, Madrid, Spain. Accessed Oct. 27, 2017.
  2. Neelapu SS, et al. Chimeric antigen receptor T-cell therapy: Assessment and management of toxicities. Nature Reviews Clinical Oncology. 2018;15:47.